ArticlePediatric nephrology (Berlin, Germany)2026

Tiopronin safety in cystinuria: first real-world pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS): an EAU YAU and Endourology sections review.

Rifat Burak Ergül et al.PubMed ↗Publisher ↗

No numbers read from the abstract.